Search Orphan Drug Designations and Approvals
-
Generic Name: | alitretinoin |
---|---|
Date Designated: | 01/12/2021 |
Orphan Designation: | Treatment of systemic (non-cutaneous) kaposi sarcoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Galephar Pharmaceutical Research, Inc. Carr 925 Km 6.1 Bo. Junquito HC-04 BOX 4540 Humacao, Puerto Rico 00791 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-